P-116 Thiopurine Metabolite, 6-Thioguanine Nucleotide, Correlates with Detection of Antibodies Again...
P-116 Thiopurine Metabolite, 6-Thioguanine Nucleotide, Correlates with Detection of Antibodies Against Infliximab in Patients with Inflammatory Bowel Disease
About this item
Full title
Author / Creator
Publisher
Oxford, UK: Oxford University Press
Journal title
Language
English
Formats
Publication information
Publisher
Oxford, UK: Oxford University Press
Subjects
More information
Scope and Contents
Contents
Infliximab (IFX) and thiopurine combination therapy is more effective than monotherapy with either agent in patients with inflammatory bowel disease (IBD). The underlying mechanism may originate from concomitant thiopurine treatment leading to higher IFX levels along with decreased immunogenicity. Influence of the main pharmacologically active thio...
Alternative Titles
Full title
P-116 Thiopurine Metabolite, 6-Thioguanine Nucleotide, Correlates with Detection of Antibodies Against Infliximab in Patients with Inflammatory Bowel Disease
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_3169868383
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_3169868383
Other Identifiers
ISSN
1078-0998
E-ISSN
1536-4844
DOI
10.1097/01.MIB.0000512635.00831.d3
